Goldman Sachs’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-563,003
| Closed | -$2.25M | – | 5739 |
|
|
2019
Q4 | $2.25M | Buy |
563,003
+353,846
| +169% | +$1.66M | ﹤0.01% | 3563 |
|
|
2019
Q3 | $1.02M | Buy |
209,157
+25,845
| +14% | +$145K | ﹤0.01% | 4014 |
|
|
2019
Q2 | $1.12M | Sell |
183,312
-12,849
| -7% | -$68.3K | ﹤0.01% | 3925 |
|
|
2019
Q1 | $1.14M | Buy |
196,161
+21,496
| +12% | +$222K | ﹤0.01% | 3983 |
|
|
2018
Q4 | $2.35M | Sell |
174,665
-48,308
| -22% | -$814K | ﹤0.01% | 3425 |
|
|
2018
Q3 | $4.33M | Sell |
222,973
-35,347
| -14% | -$753K | ﹤0.01% | 3088 |
|
|
2018
Q2 | $6.6M | Sell |
258,320
-181,287
| -41% | -$4.23M | ﹤0.01% | 2762 |
|
|
2018
Q1 | $8.86M | Buy |
439,607
+233,630
| +113% | +$5.45M | ﹤0.01% | 2438 |
|
|
2017
Q4 | $4.13M | Buy |
205,977
+10,573
| +5% | +$208K | ﹤0.01% | 3183 |
|
|
2017
Q3 | $4.05M | Buy |
195,404
+61,536
| +46% | +$1.04M | ﹤0.01% | 3354 |
|
|
2017
Q2 | $1.98M | Buy |
133,868
+18,348
| +16% | +$306K | ﹤0.01% | 3849 |
|
|
2017
Q1 | $1.84M | Sell |
115,520
-28,494
| -20% | -$411K | ﹤0.01% | 3829 |
|
|
2016
Q4 | $1.81M | Buy |
144,014
+78,871
| +121% | +$1.47M | ﹤0.01% | 3939 |
|
|
2016
Q3 | $1.82M | Buy |
65,143
+26,010
| +66% | +$873K | ﹤0.01% | 3915 |
|
|
2016
Q2 | $1.37M | Sell |
39,133
-20,148
| -34% | -$633K | ﹤0.01% | 3934 |
|
|
2016
Q1 | $1.62M | Buy |
59,281
+21,858
| +58% | +$644K | ﹤0.01% | 3668 |
|
|
2015
Q4 | $1.28M | Sell |
37,423
-6,199
| -14% | -$193K | ﹤0.01% | 4053 |
|
|
2015
Q3 | $1.25M | Buy |
43,622
+41,004
| +1,566% | +$1.75M | ﹤0.01% | 4252 |
|
|
2015
Q2 | $117K | Sell |
2,618
-11,571
| -82% | -$435K | ﹤0.01% | 6529 |
|
|
2015
Q1 | $491K | Sell |
14,189
-14,128
| -50% | -$384K | ﹤0.01% | 5148 |
|
|
2014
Q4 | $775K | Buy |
+28,317
| New | +$687K | ﹤0.01% | 4851 |
|
Other funds holding DPLO
Goldman Sachs's DPLO Position: Q1 2020 in Review
Goldman Sachs sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 563,003 shares — an estimated $2.25M sold.
Goldman Sachs first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $8.86M in Q1 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Goldman Sachs reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Goldman Sachs sold 563,003 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $2.25M.
- Goldman Sachs first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Goldman Sachs's DIPLOMAT PHARMACY, INC. position peaked at $8.86M in Q1 2018.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.